-
Je něco špatně v tomto záznamu ?
Modulation of UCP2 expression by P38 - a link to cardioprotection
Eva Valouskova, Martin Modriansky
Jazyk angličtina Země Česko
Typ dokumentu přehledy
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
- MeSH
- financování organizované MeSH
- iontové kanály MeSH
- ischemická choroba srdeční enzymologie MeSH
- kardiomyocyty metabolismus účinky léků MeSH
- kardiotonika farmakologie terapeutické užití MeSH
- lidé MeSH
- medicína založená na důkazech MeSH
- MEDLINE využití MeSH
- mitochondriální proteiny MeSH
- mitogenem aktivované proteinkinasy p38 MeSH
- oxidativní fosforylace MeSH
- reaktivní formy kyslíku chemie metabolismus MeSH
- rozpřahující látky chemie MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
Background: Discovery of uncoupling protein 2 (UCP2) in 1997 and demonstration of its wide tissue expressionhas triggered an important question about controlled oxidative phosphorylation uncoupling and the physiologicalfunction of this process. Uncoupling protein 2 (UcP2) is a mitochondrial protein that can infl uence the mitochondrialmembrane potential and hence the production of reactive oxygen species by mitochondria. It is also thought to beinvolved in apoptotic signaling pathways and it has been suggested to be important in cardio- and neuroprotection.Methods and results: We examined the recent literature (2003–2007) in the MedLine database for evidence linkingp38, one of the stress-related protein kinases, with modulation of UCP2 expression in the heart. While two reportsclearly demonstrate p38 as down-regulating UcP2 expression, only circumstantial evidence exists for cardiomyocytes.Confl icting results on p38-regulated cardiomyocyte survival after ischemia leave an open venue for hypotheses on thediff erential regulation of protein expression, including UCP2. Conclusions: Reviewing the evidence connecting UCP2 and its cytoprotective activities, we propose a tissue specifi clink that may explain the variable infl uence of p38 via modulation of UCP2 expression.
Citace poskytuje Crossref.org
Lit.: 76
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10009293
- 003
- CZ-PrNML
- 005
- 20111210162306.0
- 008
- 100419s2008 xr e eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2008.001 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Gabrielová, Eva. $7 xx0267682
- 245 10
- $a Modulation of UCP2 expression by P38 - a link to cardioprotection / $c Eva Valouskova, Martin Modriansky
- 314 __
- $a Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Olomouc
- 504 __
- $a Lit.: 76
- 520 9_
- $a Background: Discovery of uncoupling protein 2 (UCP2) in 1997 and demonstration of its wide tissue expressionhas triggered an important question about controlled oxidative phosphorylation uncoupling and the physiologicalfunction of this process. Uncoupling protein 2 (UcP2) is a mitochondrial protein that can infl uence the mitochondrialmembrane potential and hence the production of reactive oxygen species by mitochondria. It is also thought to beinvolved in apoptotic signaling pathways and it has been suggested to be important in cardio- and neuroprotection.Methods and results: We examined the recent literature (2003–2007) in the MedLine database for evidence linkingp38, one of the stress-related protein kinases, with modulation of UCP2 expression in the heart. While two reportsclearly demonstrate p38 as down-regulating UcP2 expression, only circumstantial evidence exists for cardiomyocytes.Confl icting results on p38-regulated cardiomyocyte survival after ischemia leave an open venue for hypotheses on thediff erential regulation of protein expression, including UCP2. Conclusions: Reviewing the evidence connecting UCP2 and its cytoprotective activities, we propose a tissue specifi clink that may explain the variable infl uence of p38 via modulation of UCP2 expression.
- 650 _2
- $a rozpřahující látky $x chemie $7 D014475
- 650 _2
- $a iontové kanály $7 D007473
- 650 _2
- $a mitochondriální proteiny $7 D024101
- 650 _2
- $a mitogenem aktivované proteinkinasy p38 $7 D048051
- 650 _2
- $a oxidativní fosforylace $7 D010085
- 650 _2
- $a reaktivní formy kyslíku $x chemie $x metabolismus $7 D017382
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a ischemická choroba srdeční $x enzymologie $7 D017202
- 650 _2
- $a kardiomyocyty $x metabolismus $x účinky léků $7 D032383
- 650 _2
- $a kardiotonika $x farmakologie $x terapeutické užití $7 D002316
- 650 _2
- $a medicína založená na důkazech $7 D019317
- 650 _2
- $a MEDLINE $x využití $7 D016239
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a financování organizované $7 D005381
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Modrianský, Martin, $d 1966- $7 xx0042117
- 773 0_
- $w MED00012606 $t Biomedical papers $g Roč. 152, č. 1 (2008), s. 3-7 $x 1213-8118
- 856 41
- $u http://biomed.papers.upol.cz/pdfs/bio/2008/01/01.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 8
- 990 __
- $a 20100419115931 $b ABA008
- 991 __
- $a 20100507185510 $b ABA008
- 999 __
- $a ok $b bmc $g 723167 $s 586282
- BAS __
- $a 3
- BMC __
- $a 2008 $b 152 $c 1 $d 3-7 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x MED00012606
- LZP __
- $a 2010-22/dkal